Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report

Código QR

Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report

Here, we discuss the safety and management of adverse events associated with pembrolizumab plus axitinib combination therapy for metastatic renal cell carcinoma in patients on hemodialysis. A 76-year-old man was diagnosed with cT3aN0M0 renal cell carcinoma due to gross hematuria. Stereoscopic radiot...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yuki Katsumata, Yoshihide Kawasaki, Kayu Tanaka, Daisuke Nakayama, Hiromichi Katayama, Shuichi Shimada, Yohei Satake, Takuma Sato, Naoki Kawamorita, Shinichi Yamashita, Testuya Sato, Kosuke Shoji, Koji Mitsuzuka, Akihiro Ito
Formato:	article
Lenguaje:	EN
Publicado:	Karger Publishers 2021
Materias:	axitinib hemodialysis pembrolizumab renal cell carcinoma Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/f836686a18da49219a96dc9f58f4a191
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A case of von Hippel–Lindau disease with renal cell carcinoma treated by partial nephrectomy with pre- and post-surgical axitinib therapy
por: Takahiro Akioka, et al.
Publicado: (2022)

A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
por: Wu L, et al.
Publicado: (2021)

Robust response of pulmonary pleomorphic carcinoma to pembrolizumab and sequential radiotherapy: A case report
por: Tae‐Hun Kim, et al.
Publicado: (2021)

Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab
por: Terufumi Yoshida, et al.
Publicado: (2021)

Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report
por: Anna E. Protasova, et al.
Publicado: (2021)

Pembrolizumab-Induced Lichen Planus on the Scalp of a Patient with Non-Small-Cell Lung Carcinoma
por: Aya Yamashita, et al.
Publicado: (2021)

Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
por: Marc-Oliver Grimm, et al.
Publicado: (2021)

Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer
por: Noguchi S, et al.
Publicado: (2020)

First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis
por: Youwen Zhu, et al.
Publicado: (2021)

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
por: Luis de la Cruz-Merino, et al.
Publicado: (2021)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
por: Tian Zeng, et al.
Publicado: (2021)

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
por: Kei Sonehara, et al.
Publicado: (2021)

Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study
por: Toshiki Ogiwara, et al.
Publicado: (2021)

Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
por: Jean-Louis Pujol, MD, PhD, et al.
Publicado: (2021)

Nanotubular TiO2 regulates macrophage M2 polarization and increases macrophage secretion of VEGF to accelerate endothelialization via the ERK1/2 and PI3K/AKT pathways
por: Xu WC, et al.
Publicado: (2019)

Epidemiología de la hipertensión en hemodiálisis crónica
por: Vukusich C,Antonio, et al.
Publicado: (2002)

Hemodialysis international
Publicado: (2000)

Relationship between hemodialysis and health-related quality of life: a cross-sectional study of diagnosis and duration of hemodialysis
por: Shinichi Noto, et al.
Publicado: (2021)

Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report
por: Motoyasu Kato, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Pembrolizumab Plus Pemetrexed and Platinum Versus Chemotherapy Alone as First-Line Treatment in Metastatic Non-Squamous Non–Small Cell Lung Cancer: A Reconstruction of Partitioned Survival Model Based on Time Dependent Pricing Mechanism of Patient Assistance Program
por: Yuanyi Cai, et al.
Publicado: (2021)

Efecto de la midodrina en la hipotensión sintomática en hemodiálisis
por: Cotera F,Alejandro, et al.
Publicado: (2002)

Síndrome de piernas inquietas: Estudio clínico en población general adulta y en pacientes urémicos
por: Miranda C,Marcelo, et al.
Publicado: (2001)

Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy
por: Selina K. Wong, et al.
Publicado: (2021)

Entendiendo las terapias actuales en melanoma metastásico
por: Rodríguez,Rocío, et al.
Publicado: (2016)

Early complications of translumbar cannulation of the inferior vena cava as a quick, last-chance method of gaining access for hemodialysis. Ten years of experience in one clinical center
por: Jarosław Leś, et al.
Publicado: (2020)

Dialysis Adequacy and Risk of Dementia in Elderly Hemodialysis Patients
por: Hyung Woo Kim, et al.
Publicado: (2021)

Combination of Multiple Hemodialysis Modes: Better Treatment Options for Patients Under Maintenance Hemodialysis
por: Zhang ZY, et al.
Publicado: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
por: Zoe Apalla, et al.
Publicado: (2021)

Duodenal Metastasis of Pulmonary Pleomorphic Carcinoma: A Case Report
por: Masayuki Matsuda, et al.
Publicado: (2021)

Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective Study
por: Xiaozhun Huang, et al.
Publicado: (2021)

Prevalencia de desnutrición calórico proteica en pacientes hemodializados crónicos
por: Huidobro M,Andrea, et al.
Publicado: (2001)

Bacteriemia por Ochrobactrum anthropi en paciente en hemodiálisis por catéter tunelizado permanente: Caso clínico
por: Obando M,Nicolás, et al.
Publicado: (2011)

Radioyodo como tratamiento de hipertiroidismo en un paciente en hemodiálisis: Caso clínico
por: Hurtado,Claudia, et al.
Publicado: (2017)

Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
por: Ansari J, et al.
Publicado: (2013)

Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
por: Alvo A,Miriam, et al.
Publicado: (2002)

Angina mesentérica: causa infrecuente de dolor crónico en paciente en hemodiálisis
por: Duclos H,Jaime, et al.
Publicado: (2002)

Calcium and phosphorus parameters and their association with serum parathormone in chronic kidney patients on hemodialysis
por: Mendes,Vitória Ribeiro, et al.
Publicado: (2021)

Hodgkin lymphoma. ASCO, EHA and ASH 2020 news
por: Elena A. Demina
Publicado: (2021)

Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma
por: Oncale MB, et al.
Publicado: (2017)

Seminars in dialysis
Publicado: (1988)